IOVANCE BIOTHERAPEUTICS ($IOVA) posted quarterly earnings results for Q3 2026 on Thursday, November 5th. The company reported earnings of -$0.05 per share, beating estimates of -$0.09 by $0.04. The company also reported revenue of $121,470,000, beating estimates of $117,838,560 by $3,631,440.
You can see Quiver Quantitative's $IOVA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IOVANCE BIOTHERAPEUTICS Hedge Fund Activity
We have seen 175 institutional investors add shares of IOVANCE BIOTHERAPEUTICS stock to their portfolio, and 102 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVENOMIC CAPITAL MANAGEMENT LP removed 7,012,956 shares (-82.5%) from their portfolio in Q2 2026, for an estimated $29,173,896
- BLACKROCK, INC. added 5,877,176 shares (+18.9%) to their portfolio in Q2 2026, for an estimated $24,449,052
- TWO SIGMA INVESTMENTS, LP added 5,323,264 shares (+38.9%) to their portfolio in Q2 2026, for an estimated $22,144,778
- JUPITER ASSET MANAGEMENT LTD added 4,535,080 shares (+inf%) to their portfolio in Q2 2026, for an estimated $18,865,932
- GOLDMAN SACHS GROUP INC removed 3,663,726 shares (-41.8%) from their portfolio in Q2 2026, for an estimated $15,241,100
- BANK OF AMERICA CORP /DE/ removed 3,496,535 shares (-41.2%) from their portfolio in Q2 2026, for an estimated $14,545,585
- AQR CAPITAL MANAGEMENT LLC added 3,245,416 shares (+520.0%) to their portfolio in Q2 2026, for an estimated $13,500,930
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
